Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)
CNY 3.4
(-0.58%)
CNY 3.4
(-0.58%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 287.23 Million CNY | 28.02% |
| 2022 | 224.37 Million CNY | -40.0% |
| 2021 | 373.95 Million CNY | 115.51% |
| 2020 | 173.52 Million CNY | -26.57% |
| 2019 | 236.3 Million CNY | 118.22% |
| 2018 | -1.29 Billion CNY | -505.97% |
| 2017 | 319.38 Million CNY | 29.82% |
| 2016 | 246.01 Million CNY | 41.08% |
| 2015 | 174.37 Million CNY | 20.45% |
| 2014 | 144.77 Million CNY | 259.79% |
| 2013 | 40.23 Million CNY | -15.87% |
| 2012 | 47.82 Million CNY | 3.8% |
| 2011 | 46.07 Million CNY | 22.04% |
| 2010 | 37.75 Million CNY | -18.65% |
| 2009 | 46.41 Million CNY | 38.09% |
| 2008 | 33.61 Million CNY | 12.38% |
| 2007 | 29.91 Million CNY | 71.4% |
| 2006 | 17.45 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 56.05 Million CNY | -4.71% |
| 2024 Q3 | 61.71 Million CNY | 10.09% |
| 2024 Q1 | 58.82 Million CNY | 44.68% |
| 2023 Q2 | 103.07 Million CNY | 94.69% |
| 2023 Q3 | 90.55 Million CNY | -12.15% |
| 2023 FY | 287.23 Million CNY | 28.02% |
| 2023 Q4 | 40.65 Million CNY | -55.1% |
| 2023 Q1 | 52.94 Million CNY | 737.45% |
| 2022 Q1 | 73.47 Million CNY | 17.02% |
| 2022 FY | 224.37 Million CNY | -40.0% |
| 2022 Q4 | -8.3 Million CNY | -107.58% |
| 2022 Q3 | 109.53 Million CNY | 88.78% |
| 2022 Q2 | 58.02 Million CNY | -21.03% |
| 2021 Q1 | 72.18 Million CNY | 43.47% |
| 2021 Q3 | 57.44 Million CNY | -28.59% |
| 2021 Q4 | 62.79 Million CNY | 9.3% |
| 2021 FY | 373.95 Million CNY | 115.51% |
| 2021 Q2 | 80.44 Million CNY | 11.45% |
| 2020 Q1 | -13.01 Million CNY | -136.01% |
| 2020 Q4 | 50.31 Million CNY | -42.47% |
| 2020 FY | 173.52 Million CNY | -26.57% |
| 2020 Q3 | 87.46 Million CNY | 79.35% |
| 2020 Q2 | 48.76 Million CNY | 474.64% |
| 2019 Q1 | 61.8 Million CNY | 103.96% |
| 2019 Q4 | 36.14 Million CNY | -54.15% |
| 2019 Q2 | 59.51 Million CNY | -3.71% |
| 2019 Q3 | 78.83 Million CNY | 32.46% |
| 2019 FY | 236.3 Million CNY | 118.22% |
| 2018 Q4 | -1.56 Billion CNY | -2385.48% |
| 2018 Q3 | 68.28 Million CNY | -44.02% |
| 2018 Q2 | 121.98 Million CNY | 65.61% |
| 2018 FY | -1.29 Billion CNY | -505.97% |
| 2018 Q1 | 73.65 Million CNY | 1.2% |
| 2017 Q3 | 100.07 Million CNY | 6.32% |
| 2017 Q2 | 94.11 Million CNY | 79.58% |
| 2017 FY | 319.38 Million CNY | 29.82% |
| 2017 Q1 | 52.41 Million CNY | 13.91% |
| 2017 Q4 | 72.78 Million CNY | -27.27% |
| 2016 FY | 246.01 Million CNY | 41.08% |
| 2016 Q2 | 86.36 Million CNY | 98.04% |
| 2016 Q3 | 70.02 Million CNY | -18.91% |
| 2016 Q4 | 46.01 Million CNY | -34.3% |
| 2016 Q1 | 43.6 Million CNY | 0.5% |
| 2015 FY | 174.37 Million CNY | 20.45% |
| 2015 Q2 | 48.36 Million CNY | 46.34% |
| 2015 Q1 | 33.05 Million CNY | -43.46% |
| 2015 Q4 | 43.39 Million CNY | -12.47% |
| 2015 Q3 | 49.57 Million CNY | 2.49% |
| 2014 Q2 | 40.21 Million CNY | 555.57% |
| 2014 Q1 | 6.13 Million CNY | -54.34% |
| 2014 Q3 | 39.97 Million CNY | -0.59% |
| 2014 FY | 144.77 Million CNY | 259.79% |
| 2014 Q4 | 58.45 Million CNY | 46.24% |
| 2013 Q1 | 7.1 Million CNY | -52.37% |
| 2013 Q2 | 10.86 Million CNY | 52.97% |
| 2013 Q3 | 8.83 Million CNY | -18.68% |
| 2013 Q4 | 13.43 Million CNY | 52.03% |
| 2013 FY | 40.23 Million CNY | -15.87% |
| 2012 FY | 47.82 Million CNY | 3.8% |
| 2012 Q1 | 7.07 Million CNY | -52.0% |
| 2012 Q2 | 16.95 Million CNY | 139.74% |
| 2012 Q3 | 8.88 Million CNY | -47.61% |
| 2012 Q4 | 14.91 Million CNY | 67.87% |
| 2011 Q3 | 8.15 Million CNY | -50.99% |
| 2011 Q2 | 16.63 Million CNY | 153.5% |
| 2011 Q1 | 6.56 Million CNY | -17.03% |
| 2011 FY | 46.07 Million CNY | 22.04% |
| 2011 Q4 | 14.73 Million CNY | 80.79% |
| 2010 Q1 | 6.34 Million CNY | -65.0% |
| 2010 Q2 | 15.93 Million CNY | 151.12% |
| 2010 FY | 37.75 Million CNY | -18.65% |
| 2010 Q4 | 7.9 Million CNY | 4.46% |
| 2010 Q3 | 7.56 Million CNY | -52.5% |
| 2009 FY | 46.41 Million CNY | 38.09% |
| 2009 Q1 | 5.03 Million CNY | 0.0% |
| 2009 Q2 | 11.69 Million CNY | 132.26% |
| 2009 Q4 | 18.13 Million CNY | 51.23% |
| 2009 Q3 | 11.98 Million CNY | 2.49% |
| 2008 FY | 33.61 Million CNY | 12.38% |
| 2007 FY | 29.91 Million CNY | 71.4% |
| 2006 FY | 17.45 Million CNY | 0.0% |